"N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka jako zdroj nov\u00FDch d\u016Fle\u017Eit\u00FDch informac\u00ED k prediktivn\u00EDm a prognostick\u00FDm faktor\u016Fm u karcinomu prsu" . "M\u011B\u0159i\u010Dka, Pavel" . . "Jand\u00EDk, Pavel" . "The Tumor Tissue Bank containing cryopreserved samples unables development of new diagnostic methods based on molecular biologic and genetic analyses. Our study started in June 2008. In our study were taken and samples from 156 female patients. The results reported here represent the 3-year period of follow up. 316 women with breast carcinoma, mean age 65.2 years (age range 27 to 88 years) were admitted to this project. The aim of our study was to design a program of record-keeping and assessment of predictive and prognostic factors obtained with new molecular biologic and genetic methods. Utilization of new technologies in the treatment of cancer such as biotechnology and nanotechnology demand searching of %22new%22 predictive and prognostic factors that will suitably supplement the choice of therapy."@en . . . "RIV/00216208:11150/13:10196497!RIV14-MSM-11150___" . . "RIV/00216208:11150/13:10196497" . "[5467AE9D5ABF]" . "6"^^ . "6" . . . . "7" . . "90452" . . "The tumor tissue bank as a source of new important information to predictive and prognostic factors in breast cancer"@en . "N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka obsahuj\u00EDc\u00ED kryokonzerovan\u00E9 vzorky n\u00E1dorov\u00FDch tk\u00E1n\u00ED umo\u017E\u0148uje rozvoj nov\u00FDch diagnostick\u00FDch postup\u016F zalo\u017Een\u00FDch na metod\u00E1ch molekul\u00E1rn\u011B-biologick\u00FDch a genetick\u00FDch anal\u00FDz. Na\u0161e studie byla zah\u00E1jena v \u010Dervnu 2008. Prezentovan\u00E9 v\u00FDsledky p\u0159edstavuj\u00ED obdob\u00ED p\u011Bti let (follow up). Celkov\u00FD po\u010Det nemocn\u00FDch \u017Een s karcinomem prsu, kter\u00E9 byly za\u0159azeny do projektu, byl 233 pacientek, pr\u016Fm\u011Brn\u00FD v\u011Bk 65,2 roku (v\u011Bkov\u00FD rozd\u00EDl 27-88 let). V na\u0161\u00ED studii byly odebr\u00E1ny a kryokonzervov\u00E1ny vzorky od 156 nemocn\u00FDch \u017Een. C\u00EDlem na\u0161\u00ED studie je vytvo\u0159it program evidence a hodnocen\u00ED prediktivn\u00EDch a prognostick\u00FDch faktor\u016F analyzovan\u00FDch nov\u00FDmi molekul\u00E1rn\u011B-biologick\u00FDmi a genetick\u00FDmi metodami. Vyu\u017E\u00EDv\u00E1n\u00ED nov\u00FDch technologick\u00FDch postup\u016F v l\u00E9\u010Db\u011B n\u00E1dorov\u00FDch onemocn\u011Bn\u00ED jako jsou nap\u0159. biotechnologie a nanotechnologie, vy\u017Eaduj\u00EDc\u00ED hled\u00E1n\u00ED %22nov\u00FDch%22 prediktivn\u00EDch a prognostick\u00FDch faktor\u016F, kter\u00E9 budou vhodn\u011B dopl\u0148ovat v\u00FDb\u011Br l\u00E9\u010Dby." . "Onkologie" . "N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka jako zdroj nov\u00FDch d\u016Fle\u017Eit\u00FDch informac\u00ED k prediktivn\u00EDm a prognostick\u00FDm faktor\u016Fm u karcinomu prsu"@cs . "4"^^ . "Filip, Stanislav" . "The tumor tissue bank as a source of new important information to predictive and prognostic factors in breast cancer"@en . "\u0158ez\u00E1\u010Dov\u00E1, Martina" . . "Ma\u010Dingov\u00E1, Zuzana" . "tumor tissue bank; predictive and prognostic factors; breast carcinoma"@en . "1802-4475" . "5"^^ . . "Filipov\u00E1, Al\u017Eb\u011Bta" . . . . . "N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka jako zdroj nov\u00FDch d\u016Fle\u017Eit\u00FDch informac\u00ED k prediktivn\u00EDm a prognostick\u00FDm faktor\u016Fm u karcinomu prsu"@cs . "11150" . "CZ - \u010Cesk\u00E1 republika" . . . "N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka jako zdroj nov\u00FDch d\u016Fle\u017Eit\u00FDch informac\u00ED k prediktivn\u00EDm a prognostick\u00FDm faktor\u016Fm u karcinomu prsu" . "I" . . "N\u00E1dorov\u00E1 tk\u00E1\u0148ov\u00E1 banka obsahuj\u00EDc\u00ED kryokonzerovan\u00E9 vzorky n\u00E1dorov\u00FDch tk\u00E1n\u00ED umo\u017E\u0148uje rozvoj nov\u00FDch diagnostick\u00FDch postup\u016F zalo\u017Een\u00FDch na metod\u00E1ch molekul\u00E1rn\u011B-biologick\u00FDch a genetick\u00FDch anal\u00FDz. Na\u0161e studie byla zah\u00E1jena v \u010Dervnu 2008. Prezentovan\u00E9 v\u00FDsledky p\u0159edstavuj\u00ED obdob\u00ED p\u011Bti let (follow up). Celkov\u00FD po\u010Det nemocn\u00FDch \u017Een s karcinomem prsu, kter\u00E9 byly za\u0159azeny do projektu, byl 233 pacientek, pr\u016Fm\u011Brn\u00FD v\u011Bk 65,2 roku (v\u011Bkov\u00FD rozd\u00EDl 27-88 let). V na\u0161\u00ED studii byly odebr\u00E1ny a kryokonzervov\u00E1ny vzorky od 156 nemocn\u00FDch \u017Een. C\u00EDlem na\u0161\u00ED studie je vytvo\u0159it program evidence a hodnocen\u00ED prediktivn\u00EDch a prognostick\u00FDch faktor\u016F analyzovan\u00FDch nov\u00FDmi molekul\u00E1rn\u011B-biologick\u00FDmi a genetick\u00FDmi metodami. Vyu\u017E\u00EDv\u00E1n\u00ED nov\u00FDch technologick\u00FDch postup\u016F v l\u00E9\u010Db\u011B n\u00E1dorov\u00FDch onemocn\u011Bn\u00ED jako jsou nap\u0159. biotechnologie a nanotechnologie, vy\u017Eaduj\u00EDc\u00ED hled\u00E1n\u00ED %22nov\u00FDch%22 prediktivn\u00EDch a prognostick\u00FDch faktor\u016F, kter\u00E9 budou vhodn\u011B dopl\u0148ovat v\u00FDb\u011Br l\u00E9\u010Dby."@cs .